Page last updated: 2024-08-24

imiquimod and Female Genital Neoplasms

imiquimod has been researched along with Female Genital Neoplasms in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (71.43)29.6817
2010's0 (0.00)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Jonnalagadda, S; Palle, K; Reedy, M1
Bevilacqua, F; Bleeker, MCG; Bornstein, J; Carcopino, X; Chargari, C; Cruickshank, ME; Erzeneoglu, BE; Esat Temiz, B; Gallio, N; Gultekin, M; Heller, D; Joura, E; Kesic, V; Planchamp, F; Preti, M; Querleu, D; Reich, O; Stockdale, CK; Van Beurden, M; Vieira-Baptista, P; Woelber, L; Zodzika, J1
Campagne, G; Martínez, A; Roca, M1
Berencsi, G; Melles, M; Sziller, I1
Misery, L1
Gollnick, HP; Law, C; Marini, M; O'Mahony, C1
Arany, I; Diaz-Arrastia, C; Dinh, TV; Gatalica, Z; Hannigan, E; Robazetti, SC; Tyring, SK1

Reviews

1 review(s) available for imiquimod and Female Genital Neoplasms

ArticleYear
[Prevention of malignant tumors caused by human papilloma virus (HPV) by vaccination and with the methods of classical gynecologic diagnostics].
    Orvosi hetilap, 2006, Aug-06, Volume: 147, Issue:31

    Topics: Adjuvants, Immunologic; Adolescent; Aminoquinolines; Antineoplastic Agents; Biopsy; Cell Transformation, Neoplastic; Colposcopy; Female; Genital Neoplasms, Female; Humans; Imiquimod; Male; Papanicolaou Test; Papillomaviridae; Papillomavirus Infections; Tumor Virus Infections; Vaginal Smears; Viral Vaccines

2006

Other Studies

6 other study(ies) available for imiquimod and Female Genital Neoplasms

ArticleYear
Case Report: Intra-Tumoral Vaccinations of Quadrivalent HPV-L1 Peptide Vaccine With Topical TLR-7 Agonist Following Recurrence: Complete Resolution of HPV-HR-Associated Gynecologic Squamous Cell Carcinomas in Two Patients.
    Pathology oncology research : POR, 2021, Volume: 27

    Topics: Adult; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Genital Neoplasms, Female; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Imiquimod; Neoplasm Recurrence, Local; Papillomavirus Infections; Salvage Therapy; Toll-Like Receptor 7

2021
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statem
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2022, 07-04, Volume: 32, Issue:7

    Topics: Carcinoma in Situ; Cidofovir; Colposcopy; Female; Genital Neoplasms, Female; Humans; Imiquimod; Melanoma; Melanoma, Cutaneous Malignant; Paget Disease, Extramammary; Pregnancy; Skin Neoplasms; Vulvar Neoplasms

2022
Successful treatment of a high-grade intraepithelial neoplasia with imiquimod, with vulvar pemphigus as a side effect.
    European journal of obstetrics, gynecology, and reproductive biology, 2003, Aug-15, Volume: 109, Issue:2

    Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Genital Neoplasms, Female; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Pemphigus; Treatment Outcome; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Diseases; Vulvar Neoplasms

2003
Treatment of genital Paget's skin disease with topical imiquimod: severe adverse events.
    The Journal of dermatological treatment, 2007, Volume: 18, Issue:3

    Topics: Aged; Aminoquinolines; Antineoplastic Agents; Diagnosis, Differential; Drug Hypersensitivity; Female; Genital Neoplasms, Female; Humans; Imiquimod; Paget Disease, Extramammary

2007
New patient-applied therapy for anogenital warts is rated favourably by patients.
    International journal of STD & AIDS, 2001, Volume: 12, Issue:9

    Topics: Administration, Topical; Adolescent; Adult; Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Female; Follow-Up Studies; Genital Neoplasms, Female; Genital Neoplasms, Male; Health Knowledge, Attitudes, Practice; Humans; Imiquimod; Male; Surveys and Questionnaires; Time Factors; Treatment Outcome; Warts

2001
Clinical and molecular responses in high-grade intraepithelial neoplasia treated with topical imiquimod 5%.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:10

    Topics: 2',5'-Oligoadenylate Synthetase; Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Female; Follow-Up Studies; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genital Neoplasms, Female; Humans; Imiquimod; Middle Aged; Ointments; RNA, Neoplasm; Time Factors; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms

2001